The Stochastic Oscillator for AUPH moved into overbought territory on October 13, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AUPH as a result. In 78 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The 10-day moving average for AUPH crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
AUPH broke above its upper Bollinger Band on September 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Moving Average Convergence Divergence (MACD) for AUPH just turned positive on October 12, 2026. Looking at past instances where AUPH's MACD turned positive, the stock continued to rise in 41 of 50 cases over the following month. The odds of a continued upward trend are 82%.
AUPH moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where AUPH advanced for three days, in 220 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Tickeron SMR rating for this company is 18 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. AUPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.575) is normal, around the industry mean (26.782). P/E Ratio (7.248) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (7.429) is also within normal values, averaging (437.542).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Aroon Indicator for MLTX entered a downward trend on October 13, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 122 similar instances where the Aroon Indicator formed such a pattern. In 99 of the 122 cases the stock moved lower. This puts the odds of a downward move at 81%.
The 50-day moving average for MLTX moved below the 200-day moving average on September 17, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 69 cases where MLTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for MLTX just turned positive on September 30, 2026. Looking at past instances where MLTX's MACD turned positive, the stock continued to rise in 45 of 56 cases over the following month. The odds of a continued upward trend are 80%.
Following a +7.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLTX advanced for three days, in 256 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
MLTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.298) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. MLTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 98 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
AUPH | MLTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 59 Fair valued | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 98 | |
SMR RATING 1..100 | 18 | 98 | |
PRICE GROWTH RATING 1..100 | 43 | 65 | |
P/E GROWTH RATING 1..100 | 98 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 47 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MLTX's Valuation (24) in the null industry is somewhat better than the same rating for AUPH (59) in the Biotechnology industry. This means that MLTX’s stock grew somewhat faster than AUPH’s over the last 12 months.
MLTX's Profit vs Risk Rating (98) in the null industry is in the same range as AUPH (100) in the Biotechnology industry. This means that MLTX’s stock grew similarly to AUPH’s over the last 12 months.
AUPH's SMR Rating (18) in the Biotechnology industry is significantly better than the same rating for MLTX (98) in the null industry. This means that AUPH’s stock grew significantly faster than MLTX’s over the last 12 months.
AUPH's Price Growth Rating (43) in the Biotechnology industry is in the same range as MLTX (65) in the null industry. This means that AUPH’s stock grew similarly to MLTX’s over the last 12 months.
AUPH's P/E Growth Rating (98) in the Biotechnology industry is in the same range as MLTX (100) in the null industry. This means that AUPH’s stock grew similarly to MLTX’s over the last 12 months.
| AUPH | MLTX | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 87% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 76% | N/A |
| MACD ODDS (%) | 2 days ago 82% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 73% |
| Advances ODDS (%) | 6 days ago 80% | 23 days ago 84% |
| Declines ODDS (%) | 2 days ago 75% | 2 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 80% | 6 days ago 89% |
| Aroon ODDS (%) | N/A | 2 days ago 81% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AUPH’s FA Score shows that 1 FA rating(s) are green while MLTX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AUPH’s TA Score shows that 3 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).
AUPH (@Biotechnology) experienced а +4.27% price change this week, while MLTX (@Biotechnology) price change was -4.93% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -8.49%. For the same industry, the average monthly price growth was -19.00%, and the average quarterly price growth was -19.88%.
AUPH is expected to report earnings on Oct 29, 2026.
MLTX is expected to report earnings on Nov 17, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PCEB | 23.14 | 0.16 | +0.72% |
| Polen Euro High Yield Bond ETF (PCEB) | |||
| HOLA | 55.21 | 0.12 | +0.22% |
| JPMorgan International Hedged Equity Laddered Overlay ETF (HOLA) | |||
| ITDB | 34.93 | 0.03 | +0.09% |
| iShares LifePath Target Date 2030 ETF (ITDB) | |||
| KXI | 67.91 | 0.02 | +0.03% |
| iShares Global Consumer Staples ETF (KXI) | |||
| DVXY | 22.64 | N/A | N/A |
| Webs Defined Volatility Xly ETF | |||
A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with KALA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then KALA could also see price increases.
| Ticker / NAME | Correlation To AUPH | 1D Price Change % | ||
|---|---|---|---|---|
| AUPH | 100% | -1.15% | ||
| KALA - AUPH | 46% Loosely correlated | -7.14% | ||
| MLTX - AUPH | 44% Loosely correlated | -2.53% | ||
| JSPR - AUPH | 44% Loosely correlated | -10.70% | ||
| VCYT - AUPH | 39% Loosely correlated | -2.07% | ||
| GOSS - AUPH | 37% Loosely correlated | +5.17% | ||
More | ||||